Amprius Technologies (AMPX) Stock Rallies 8% After Beating Q4 Estimates

TLDR

• Amprius reported Q4 EPS of -$0.01, beating the -$0.05 consensus estimate by $0.04
• Revenue came in at $25.23M, topping the $22.91M–$24.5M analyst estimate
• The stock rose ~8% to $12.56 following the earnings release
• Insiders sold over 2.39 million shares worth ~$26.4M in the last three months
• Wall Street consensus is “Moderate Buy” with an average price target of $16.63

Amprius Technologies beat Wall Street expectations in its fourth quarter results, sending the stock up around 8% on Wednesday.

The company posted EPS of -$0.01, coming in $0.03 to $0.04 better than the consensus estimate of -$0.04 to -$0.05. Revenue hit $25.23 million, clearing estimates that ranged from $22.91M to $24.5M.

The stock closed at $12.56 during midday trading, up $0.93 on the day. Trading volume reached 9.53 million shares, above its average of 8.12 million.

Amprius Technologies, Inc., AMPX

Despite the beat, the underlying numbers still show a company in the red. Net loss for the quarter came in at $24.4 million, up from $11 million in the prior year period.

Net margin sat at -53.16% and return on equity at -38.85%. Those aren’t pretty numbers, but the market focused on the beat and the direction of travel.

For fiscal year 2026, Amprius guided for EPS of approximately -$0.06, which reflects continued losses ahead.

Insider Selling Draws Attention

While the earnings print was well-received, insider activity tells a more cautious story.

CTO Constantin Ionel Stefan sold 492,827 shares on January 22nd at an average of $12.04 per share, netting roughly $5.93 million. That transaction cut his position by 39.7%.

Director Kang Sun sold 950,548 shares on January 16th at $11.07 per share, totaling about $10.52 million — a 40.38% reduction in his stake.

In total, insiders have sold 2,392,269 shares worth approximately $26.4 million over the past three months. Insiders now hold 12.8% of the stock.

Institutional ownership stands at 5.04%. Bank of America increased its stake by 31.1% in Q4, while Rhumbline Advisers lifted its position by 61.1%.

Analyst Ratings and Price Targets

The analyst community is broadly positive on AMPX.

Needham initiated coverage on January 29th with a Buy rating and a $20 price target. Craig Hallum started coverage on February 23rd, also at Buy with a $17 target.

Cantor Fitzgerald raised its target from $12 to $16 with an Overweight rating. Oppenheimer reaffirmed an Outperform rating and a $17 target in December.

Weiss Ratings is the lone dissenter, maintaining a Sell rating.

Eight analysts currently rate the stock Buy, and one rates it Sell. The consensus sits at “Moderate Buy” with an average price target of $16.63.

The stock has a 52-week low of $1.70 and a 52-week high of $16.03, and is up 506% over the past 12 months.

Amprius is scheduled to present at the Cantor Global Tech Conference and other investor meetings in March, which management flagged as part of its investor outreach efforts.

The post Amprius Technologies (AMPX) Stock Rallies 8% After Beating Q4 Estimates appeared first on CoinCentral.